Pharmacokinetic Alteration of99m Tc-MAG3 using Serum Protein Binding Displacement Method

Abstract Introduction When a radiopharmaceutical is simultaneously administered with a medicine that has high affinity for the same plasma protein, the radiopharmaceutical is released at higher concentrations in blood, leading to enhanced transfer into target tissues. This is known as the serum prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nuclear medicine and biology 2013, Vol.40 (3), p.366-370
Hauptverfasser: Nishi, Kodai, Kobayashi, Masato, Nishii, Ryuichi, Shikano, Naoto, Takamura, Norito, Kuga, Noriyuki, Yamasaki, Keishi, Nagamachi, Shigeki, Tamura, Shozo, Otagiri, Masaki, Kawai, Keiichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Introduction When a radiopharmaceutical is simultaneously administered with a medicine that has high affinity for the same plasma protein, the radiopharmaceutical is released at higher concentrations in blood, leading to enhanced transfer into target tissues. This is known as the serum protein binding displacement method. In this study, we investigated the pharmacokinetic alteration of technetium-99m-labeled mercaptoacetylglycylglycylglycine (99m Tc-MAG3) using the serum protein binding displacement method. Methods Rat and human serum protein binding rates of99m Tc-MAG3 were measured by ultrafiltration with or without displacers of human serum albumin (HSA) binding sites I and II (200 μM and 400 μM loading). Male Wistar rats were injected with99m Tc-MAG3 (740 kBq/0.3 mL saline) via the tail vein, and biodistribution was assessed at 2, 5, 10 and 15 min. Dynamic whole-body images were obtained for99m Tc-MAG3 (11.1 MBq/0.3 mL saline)-injected rats, with or without HSA displacers. Results99m Tc-MAG3 strongly bound to HSA (87.37%±2.13%). Using HSA site I displacers, the free fraction of99m Tc-MAG3 increased significantly (1.20 to 1.47 times) when compared with controls. For biodistribution and imaging, rapid blood clearance was observed with bucolome (BCL) loading, which is an HSA site I displacer. With BCL loading, peak times for rat renograms were respectively shifted from 240 s to 110 s, and from 170 s to 120 s. Conclusions We found that99m Tc-MAG3 bound to the HSA binding site I. It was confirmed that pharmacokinetic distribution of99m Tc-MAG3 is altered by presence of BCL, which leads to increases in the free fraction of99m Tc-MAG3, and BCL produced rapid blood clearance and fast peak times on rat renograms. The serum protein binding displacement method using99m Tc-MAG3 and BCL, a safe displacer for humans, may be applicable to clinical study and lead to better diagnostic images with shorter waiting times and lower radiation doses for patients.
ISSN:0969-8051
DOI:10.1016/j.nucmedbio.2012.12.002